Literature DB >> 20727465

Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease.

Andrea D Valderrey1, María José Pozuelo, Pedro A Jiménez, María D Maciá, Antonio Oliver, Rafael Rotger.   

Abstract

Pseudomonas aeruginosa is isolated in sputum cultures from cystic fibrosis (CF) patients and adults with bronchiectasis (BS) and chronic obstructive pulmonary disease, but it is not well known if the characteristics of colonization in these latter patients are similar to those with CF. We examined 125 P. aeruginosa isolates obtained from 31 patients suffering from these diseases by pulsed field gel electrophoresis and genotyping of mucA and fpvA genes. The pattern of colonization, with dominance of a clonal strain and incidence of mucoid phenotypes, was similar in every group of patients; however, in some CF and BS patients, we detected the replacement or coexistence of 2 main clones. The main differences were found in the nucleotide position of less common mucA mutations, other than mucA22, and in the predominance of the different types of the pyoverdine receptor. Our results support a similar colonization pattern by P. aeruginosa in the different obstructive pulmonary diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727465     DOI: 10.1016/j.diagmicrobio.2010.04.008

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  26 in total

1.  A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.

Authors:  Manon F Pritchard; Lydia C Powell; Alison A Jack; Kate Powell; Konrad Beck; Hannah Florance; Julian Forton; Philip D Rye; Arne Dessen; Katja E Hill; David W Thomas
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Pneumococci can persistently colonize adult patients with chronic respiratory disease.

Authors:  A Domenech; C Ardanuy; L Balsalobre; S Marti; L Calatayud; A G De la Campa; A B Brueggemann; J Liñares
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

3.  Express Yourself: Quantitative Real-Time PCR Assays for Rapid Chromosomal Antimicrobial Resistance Detection in Pseudomonas aeruginosa.

Authors:  Derek S Sarovich; Erin P Price; Danielle E Madden; Olusola Olagoke; Timothy Baird; Jane Neill; Kay A Ramsay; Tamieka A Fraser; Scott C Bell
Journal:  Antimicrob Agents Chemother       Date:  2022-04-25       Impact factor: 5.938

4.  A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities.

Authors:  David Pulido; Guillem Prats-Ejarque; Clara Villalba; Marcel Albacar; Juan J González-López; Marc Torrent; Mohammed Moussaoui; Ester Boix
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  The Concerted Action of Two B3-Like Prophage Genes Excludes Superinfecting Bacteriophages by Blocking DNA Entry into Pseudomonas aeruginosa.

Authors:  Marco Antonio Carballo-Ontiveros; Adrián Cazares; Pablo Vinuesa; Luis Kameyama; Gabriel Guarneros
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

6.  Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study.

Authors:  Heino Stass; Johannes Nagelschmitz; Stefan Willmann; Heinz Delesen; Abhishek Gupta; Sybille Baumann
Journal:  Clin Drug Investig       Date:  2013-06       Impact factor: 2.859

7.  Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens.

Authors:  Berthony Deslouches; Jonathan D Steckbeck; Jodi K Craigo; Yohei Doi; Timothy A Mietzner; Ronald C Montelaro
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

8.  Identification, molecular characterisation and antimicrobial susceptibility of genomovars of the Burkholderia cepacia complex in Spain.

Authors:  M J Medina-Pascual; S Valdezate; P Villalón; N Garrido; V Rubio; J A Saéz-Nieto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-02       Impact factor: 3.267

9.  Cell-free expression of the outer membrane protein OprF of Pseudomonas aeruginosa for vaccine purposes.

Authors:  Géraldine Mayeux; Landry Gayet; Lavinia Liguori; Marine Odier; Donald K Martin; Sandra Cortès; Béatrice Schaack; Jean-Luc Lenormand
Journal:  Life Sci Alliance       Date:  2021-05-10

Review 10.  A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence.

Authors:  Deepak Balasubramanian; Lisa Schneper; Hansi Kumari; Kalai Mathee
Journal:  Nucleic Acids Res       Date:  2012-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.